Start-up supplement brand MyOva has launched with two products for women who suffer from polycystic ovarian syndrome (PCOS) to help manage their menstrual health and aid fertility.
Formulated with scientifically-backed ingredients, the supplements incorporate myo-inositol, which can reduce PCOS symptoms, restore ovulation, increase fertility and improve egg quality.
Myoplus is designed to help PCOS sufferers rebalance, restore, and reclaim their hormonal and menstrual health. The supplement contains 4,000mg of myo-inositol per daily dose, plus 100ug chromium to balance blood sugar levels and 200ug folate, which the brand says is easier and faster for the body to absorb than folic acid. Myoplus also helps reduce menstrual cycle symptoms caused by hormonal fluctuations that affect mood, skin and energy levels, supports immunity and stabilizes glucose levels.
Preconception is positioned as ‘the only fertility supplement women with PCOS need’ when trying to conceive. It is formulated to support normal hormonal activity, which is necessary for a healthy menstrual cycle. Containing essential micronutrients to support ovulation and reproductive health, it also helps to manage a woman’s metabolic health. It contains 20 nutrients including 2,000mg myo-inositol, coenzyme Q10, n-acetyl cysteine, folate, zinc and vitamin B6.
“I am thrilled to launch MyOva, a range of Myo-inositol based supplements formulated for women with PCOS,” comments MyOva founder Leila Martyn. “As a PCOS sufferer myself, I understood first-hand how PCOS can have such a devastating effect on menstrual health and fertility and I wanted to help other women by offering a natural solution.”
Myoplus and Preconception will be joined by additional MyOva products launching throughout 2022 to complete the range: Hair, Skin & Nails, Metabolism and Balance. All products contain a daily dose of at least 2,000mg of myo-inositol and each has been specially formulated with additional vitamins and minerals to target specific health concerns.
